Clinical Trials Browser

INDUSTRY × Rifampin × Other neoplasm × Clear all

NCT06165822 2023-12-12

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Phase 1 Unknown

Advanced Malignant Neoplasm